20th Annual Clinical Meeting
Integrative Pain Management for Optimal Patient Care
October 8-11, 2009
Sheraton Phoenix Downtown Hotel, Phoenix, Arizona
REGISTER
The American Academy of
Pain Management
The American Academy of Pain Management is an inclusive, interdisciplinary/integrative organization serving clinicians who treat people with pain through education, setting standards of care, and advocacy.
Academy WebsiteBecome a Member!
Subscribe
Classified Ads
Corporate Members
Contact Us
About Us
Pain Studies In The News
Pain in people with dementia often undiagnosedSeptember 03, 2009 Source: University of Alberta
The elderly who suffer from dementia aren't able to say when something hurts or is sore. They may demonstrate their pain through behaviours like rocking or striking out, and we often dismiss these actions as symptoms of the dementia instead of pain, which is usually from a different problem. Arthritis, diabetic neuropathy, fractures, muscular contractures, bruises, abdominal pain and mouth ulcers are among the list of common ailments that go undetected. It is important for those who live or work with persons with dementia to know how to identify when an elderly person is experiencing pain - and receive treatment sooner rather than later. [Story]
Study examines effectiveness of laparoscopic surgical treatments to alleviate chronic pelvic pain
Augusts 28, 2009 Source: American Medical Association (AMA)
Media Advisory: To contact Jane Daniels, M.Sc., e-mail j.p.daniels@bham.ac.uk. A surgical procedure known as LUNA (laparoscopic uterosacral nerve ablation) did not result in improvements in chronic pelvic pain, painful menstruation, painful sexual intercourse or quality of life when compared with laparoscopic surgery that does not interrupt pelvic nerve connections, according to a recent study. [Story]
Books:
Complementary and Integrative Medicine in Pain Management
by Michael I. Weintraub, MD, FACP, FAAN, Ravinder Mamtani, MBBS, MD, MSc, and Marc S. Micozzi, MD, PhD
Publishers Description: This book is an invaluable reference for a wide range of health care providers seeking to promote the health and quality of life of patients with chronic pain by employing evidence-based complementary and integrative medicine (CIM) methods.
[More information]
Chronic Pain
by Gary W. Jay, MD.
Chronic Pain is intended to provide a conceptual framework of understanding for anyone who deals with chronic pain patients.
[More information]
Stories
Country legend Naomi Judd joins 'Partners Against Pain'August 25, 2009 Source: Purdue Pharma
Country music legend Naomi Judd is lending her voice to the national educational program Partners Against Pain to raise awareness about the urgent need to address undertreated pain in America. As a former nurse, Judd knows that chronic pain can wreak havoc on a person's mind, body and spirit. In her personal life, she has seen how it affected a close friend who suffered excruciating pain from terminal pancreatic cancer. [Story]
www.PalliativeDoctors.org: organization sheds light on hospice and palliative care
August 24, 2009 Source: American Academy of Hospice and Palliative Medicine
An organization of doctors specializing in hospice and palliative medicine has launched a new Web site -- www.PalliativeDoctors.org -- to raise awareness of this type of medical care and how it can help patients with serious illnesses, and their families. Palliative medicine is a type of care that relieves suffering through pain management, emotional support and guidance in managing a disease and making medical decisions. It is for patients with serious illnesses, regardless of their prognosis, and often is provided along with treatments designed to cure the patient's disease. A specific type of palliative care -- hospice -- is available for patients who are not expected to live more than six months if their disease follows its normal course. [Story]
Product News/Clinical Trial Results
FDA approves EMBEDA™ for management of moderate to severe chronic pain August, 2009 Source: King Phrmaceuticals
King Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules for oral use, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. EMBEDA is the first FDA-approved long-acting opioid that is designed to reduce drug liking and euphoria when tampered with by crushing or chewing. [Story]
Acura says no new trials required for pain drug now
September 3, 2009 Source: Acura Pharmaceuticals
Acura Pharmaceuticals Inc and King Pharmaceuticals Inc said the U.S. Food and Drug Administration has not requested any additional clinical trials at this time for its troubled experimental pain drug, Acurox. In July, the FDA denied approval of the drug and raised questions on the potential abuse-deterrent benefits of the drug.The FDA has not yet set a meeting date for the advisory committee's review of the new drug application for Acurox, and the companies do not expect the meeting to be convened before the end of this year. [Story]
More Product News/Clinical Trial Results
Research/Funding Opportunities
Application period for NIH grants in Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical program begins September 5th.
This FOA encourages Research Project Grant (R01) applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial,
and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial,
and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults,
or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or
human subjects are appropriate under this program announcement.
[Additional information]
Applications for Dr. Stanley C. Marinoff Vulvodynia Career Development Award now being accepted
The Dr. Stanley C. Marinoff Career Development Award was established to encourage medical professionals to pursue a clinical and/or academic interest in vulvodynia.
The purpose of the award is to provide seed money for one of the following: (i) medical research, (ii) the establishment or enhancement of a vulvar pain clinic,
or (iii) a written publication on vulvodynia. The NVA's intent is to encourage a medical professional's interest in this field and enable him/her to pursue
further clinical or academic opportunities. The $7,500 award is open to all medical and allied health care professionals. If the applicant is affiliated
with a university, he/she can have a clinical or full-time faculty appointment up to the level of assistant professor. Please submit a brief letter of
intent to Chris Veasley (chris@nva.org) by Friday, October 16, 2009. After receipt of the applicant's letter of intent, NVA will e-mail guidelines
for submitting a full proposal. The final application is due on Friday, November 13, 2009 and the award recipient(s) will be announced in January 2010.
[Additional information]
Research Abstracts
Stay up-to-date on the latest research! This section offers complete abstracts on a wide variety of pain and pain management topics that have been selected from the
National Library of Medicine.
[All Abstracts]
Some include:
Smedslund G, Mowinckel P, Heiberg T, et al.
Does the weather really matter? A cohort study of influences of weather and solar
conditions on daily variations of joint pain in patients with rheumatoid
arthritis.
[Abstract]
Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P, et al.
Efficacy and safety of Curcuma domestica extracts in patients with knee
osteoarthritis.
[Abstract]
Deer TR, Kim C, Bowman R, et al.
Intrathecal ziconotide and opioid combination therapy for noncancer pain: an
observational study.
[Abstract]
Fine PG, Mahajan G, McPherson ML.
Long-acting opioids and short-acting opioids: appropriate use in chronic pain
management.
[Abstract]
Palermo TM, Wilson AC, Peters M, et al.
Randomized controlled trial of an Internet-delivered family cognitive-behavioral
therapy intervention for children and adolescents with chronic pain.
[Abstract]
Legislative Updates
Branch of Government: Illinois. House
Title: H.B. 9
Summary: Creates the Reflex Sympathetic Dystrophy Syndrome Education Act. Provides that the Department of Public Health, subject to appropriation, shall
establish the Reflex Sympathetic Dystrophy Syndrome Education Program to promote public awareness of the syndrome and the importance of early detection, diagnosis, and
treatment. Requires a program that will educate lawyers, judges, arbitrators, and health care professionals
Sponsor: Tracy and May
Latest Action:
08/24/2009 Signed by GOVERNOR.
08/24/2009 Public Act No. 605
[full text]
Subscribe to The Pain Practitioner!
See sample articles below:
Gladys McGarey, MD: the Mother of Holistic Medicine, by Debra Nelson-Hogan (article)
If you are a member of the Academy, you are entitled to many excellent benefits including The Pain Practitioner, our quarterly magazine. If you are not an Academy member,
you can subscribe for just $35 a year!
[Subscribe!]
Recordings of the Academy's 19th Annual Meeting are Now Available!
Listen to conference presentations in the comfort of your home, office, car, computer, or MP3 player. Individual sessions on CD can be ordered at a cost of $12.00, or purchase the entire conference on CD-ROM with handouts for only $189.00.
Go to www.lawrencemg.com to place an order or call 1-800-466-1962 x7083.
Branch of Government: Illinois. House
Title: H.B. 488
Summary: Amends the Illinois Controlled Substances Act. Provides that any written prescription for a Schedule II controlled substance may be filled within 90 (rather than 7) days after issuance.
Sponsor: Lang and Feigenholtz
Latest Action:
08/10/2009 Signed by GOVERNOR.
08/10/2009 Public Act No. 166
[full text]
Branch of Government: Illinois. House
Title: H.B. 2247
Summary: Amends the Physician Assistant Practice Act of 1987, the Pharmacy Practice Act, and the Controlled Substances Act. Relates to the prescriptive authority of a physician assistance delegated by a licensed physician for any Schedule II through V controlled substances. Requires a written supervision agreement for all physician assistants to practice in the state. Sets forth guidelines for the prescriptive authority delegated to advanced practice nurses as it relates to certain controlled substances.
Sponsor: Saviano and Reitz
Latest Action:
08/11/2009 Signed by GOVERNOR.
08/11/2009 Public Act No. 268
[Full text]
Branch of Government: North Dakota. Senate
Title: S.B. 2180
Summary: Relates to limitation on prescribing drugs by physician assistants; deletes the provision that a physician assistant may not prescribe schedule II controlled substances.
Sponsor: Warner
Latest Action:
08/18/2009 Chapter Number 367
[Full text]
New Practice Guidelines
Arthritis
National Collaborating Centre for Chronic Conditions [U.K.]
Osteoarthritis. The care and management of osteoarthritis in adults.
[Summary and recommendations]
Headache
American College of Radiology
ACR Appropriateness Criteria® headache - child.
[Summary and recommendations]
Clinical Trials
Arizona
Cancer Pain
City: Scottsdale
Summary: A study to determine the side effects of fentanyl sublingual spray and to see how well it works in treating opioid-tolerant cancer patients with or without oral mucositis.
Arizona
Nervous System Diseases
City: Tucson
Summary: A study evaluating the safety and effectiveness of JNJ-42160443 in the treatment of neuropathic pain in patients with postherpetic neuralgia and post-traumatic neuralgia.
New Books
Making the Invisible Visible: A Chronic Pain Manual for Health Care Providers
By Gwenn Herman, LCSW-C, DCSW and Mary French, RN, MSW, LCSW-C
Pain Connection, 2009 A timely, unique 250-page manual including up-to-date information on chronic pain presented in a useful format that includes coping skills and strategies in handout form for clients and clinicians. Personal stories of those who experience pain as well as those who treat people with pain are included, highlighting the human experience of this health care epidemic.
The authors emphasize the importance of assisting clients to access their own innate healing ability by becoming focused on internal healing and not just on an external cure. Read about:
- Myths and misconceptions about chronic pain clients
- The Six Psychosocial Stages
- Developing a treatment plan
- Coping skills and strategies handouts for clients
- Mindfulness and chronic pain
- Co-occuring conditions, depression and trauma
- Special complementary and alternative treatments
- Pain Connection group therapy model
Price: $49.95, plus $7.95 shipping and handling fees
Table of Contents
For a 20% discount, use code PC262 when you order online here
Lagniappe
Active ingredients in marijuana found to spread and prolong painAugust 14, 2009-Source: University of Texas Medical Branch at Galveston
Interestingly enough, given recent interest in the medical use of marijuana for pain relief, experiments with rodents and humans described in a paper published in the current issue of Science suggest these "endocannabinoids," which are made within the human body, can actually amplify and prolong pain rather than damping it down.
[Story]
The American Academy of Pain Management is the nation's largest interdisciplinary/integrative organization serving clinicians
who treat people with pain through education, setting standards of care, and advocacy.
Academy Website | Become a Member! | Classified Ads | Corporate Members | Contact Us | About Us
If you no longer wish to recieve this newsletter plase unsubscribe here.